PIRATENCT07944365
Plasma Pyrophosphate Imbalance According to Phenotype and Bone Remodelling Alterations in Type 1 Neurofibromatosis - PIRATE-NF1 -
StatusNot Yet Recruiting
PhaseNot specified
SponsorUniversity Hospital, Angers
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
PPi plasma concentration.
Timeframe: Visite 1
Secondary (11)
Plasma PPI Levels in NF1 patients
Urine PPI Levels in NF1 patients
presence of a plexiform neurofibroma in NF1 patients
presence of bone abnormalities in NF1 patients
Urinary PPI measurement in newly diagnosed patients with NF1
Show 6 moreShow less
Location of plexiform neurofibromas
Calcium measurement
Phosporus measurement
Vitamine D Assay
Parathyroid hormone (PTH) measurement
Treatment with selumetinib
Arms and interventions
Diagnosed patients with NF1